HEMATOLOGIC MALIGNANCY
Clinical trials for HEMATOLOGIC MALIGNANCY explained in plain language.
Never miss a new study
Get alerted when new HEMATOLOGIC MALIGNANCY trials appear
Sign up with your email to follow new studies for HEMATOLOGIC MALIGNANCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Korean study confirms Besponsa's safety in tough blood cancer
Disease control CompletedThis study looked at 108 people in Korea with a type of blood cancer (B-cell ALL) that had come back or stopped responding to treatment. Researchers tracked side effects and how well the drug Besponsa worked in everyday hospital use. The goal was to make sure the drug is safe and…
Matched conditions: HEMATOLOGIC MALIGNANCY
Sponsor: Pfizer • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
New radiation method aims to spare lungs in blood cancer transplants
Disease control CompletedThis study tested a new, more precise way to deliver total body radiation to 36 adults with blood cancers before a stem cell transplant. The goal was to see if this technique could effectively target cancer cells while better protecting the lungs from radiation damage. The approa…
Matched conditions: HEMATOLOGIC MALIGNANCY
Phase: NA • Sponsor: NYU Langone Health • Aim: Disease control
Last updated May 11, 2026 20:39 UTC
-
Home transfusions offer comfort for advanced blood cancer patients
Symptom relief CompletedThis study looked at whether giving blood transfusions at home is practical and acceptable for people with advanced blood cancers who need regular transfusions. Ten patients with a life expectancy of six months or less took part. The goal was to see if home transfusions could be …
Matched conditions: HEMATOLOGIC MALIGNANCY
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Symptom relief
Last updated May 17, 2026 02:56 UTC
-
HIIT and weights boost recovery after stem cell transplant, study finds
Symptom relief CompletedThis study looked at whether 12 weeks of high-intensity interval training (HIIT) and resistance training can help people who had a stem cell transplant for blood cancer. It involved 16 patients and their caregivers. The goal was to see if exercise improves physical function, thin…
Matched conditions: HEMATOLOGIC MALIGNANCY
Phase: NA • Sponsor: Duke University • Aim: Symptom relief
Last updated May 15, 2026 11:54 UTC
-
Blood transfusions unlock hospice access for blood cancer patients
Symptom relief CompletedThis study looked at whether covering the cost of blood transfusions would encourage people with blood cancers to enroll in hospice earlier. Many patients delay hospice because they need regular transfusions for symptom relief, which hospices often can't afford. The study offered…
Matched conditions: HEMATOLOGIC MALIGNANCY
Phase: NA • Sponsor: Adam Olszewski • Aim: Symptom relief
Last updated May 14, 2026 12:02 UTC
-
App vs. paper: which diary boosts cancer pill adherence?
Knowledge-focused CompletedThis study tested whether a smartphone app helps cancer patients take their oral medications more consistently than a traditional paper diary. A total of 124 adults with solid tumors or blood cancers were randomly assigned to use either an electronic diary or a paper diary to tra…
Matched conditions: HEMATOLOGIC MALIGNANCY
Phase: NA • Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS • Aim: Knowledge-focused
Last updated May 17, 2026 03:08 UTC
-
Scientists map hidden germs in kids with cancer
Knowledge-focused CompletedThis study looked at the tiny organisms (bacteria and fungi) living in the mouth and nose of 62 children with leukemia or those getting a bone marrow transplant. Researchers wanted to see how these germs change before and after chemotherapy. The goal was to learn more, not to tre…
Matched conditions: HEMATOLOGIC MALIGNANCY
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated May 17, 2026 02:57 UTC
-
Vaccine shield tested: do immunocompromised patients get enough protection?
Knowledge-focused CompletedThis study looked at how well the Pfizer COVID-19 vaccine works in adults with weakened immune systems (like kidney transplant patients, people with cancer, or those on dialysis) compared to healthy adults. Researchers measured antibody levels and their ability to neutralize the …
Matched conditions: HEMATOLOGIC MALIGNANCY
Phase: PHASE4 • Sponsor: Centre Hospitalier Régional d'Orléans • Aim: Knowledge-focused
Last updated May 13, 2026 16:03 UTC
-
Heart defects may worsen outcomes for young cancer survivors
Knowledge-focused CompletedThis study looked at 800 children who survived blood cancer to see if having a congenital heart defect raises their risk of death or other health problems later in life. Researchers also checked for shared genes between the two conditions. The goal is to better understand and car…
Matched conditions: HEMATOLOGIC MALIGNANCY
Sponsor: Children's Hospital of Fudan University • Aim: Knowledge-focused
Last updated May 12, 2026 13:41 UTC
-
COVID-19 vaccine study in vulnerable kids reveals immune response
Knowledge-focused CompletedThis study looked at how well COVID-19 vaccines work in children and young adults (under 24) with cancer or who have had a transplant or cellular therapy. Researchers measured antibody and T-cell responses after vaccination to understand immune protection. The goal was to learn m…
Matched conditions: HEMATOLOGIC MALIGNANCY
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated May 06, 2026 16:15 UTC